Low-dose lenograstim is as effective as standard dose in shortening neutrophil engraftment time following myeloablative chemotherapy and peripheral blood progenitor cell rescue

L. Nolan, P. Lorigan, S. Chilton, J. Newman, R. Else, P. Smith, D. Linch, J. W. Sweetenham, P. W. Johnson

Research output: Contribution to journal › Article › peer-review